Trial Profile
Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms With Prophylactic Pentosan Polysulphate in Patients With Non-Muscle-Invasive Bladder Cancer: A Randomized Controlled Trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2022
Price :
$35
*
At a glance
- Drugs Pentosan polysulfate (Primary)
- Indications Interstitial cystitis; Pain
- Focus Adverse reactions; Therapeutic Use
- 16 Feb 2022 Status changed from suspended to discontinued.
- 24 Sep 2019 Planned End Date changed from 30 Dec 2020 to 1 Dec 2020.
- 24 Sep 2019 Status changed from recruiting to suspended.